KLP Kapitalforvaltning
RPRX icon

KLP Kapitalforvaltning’s Royalty Pharma RPRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.33M Buy
159,800
+1,600
+1% +$94.4K 0.03% 406
2026
Q2 		$8.87M Hold
158,200
– – 0.03% 419
2026
Q1 		$7.59M Buy
158,200
+26,700
+20% +$1.17M 0.03% 410
2025
Q4 		$5.08M Sell
131,500
-100
-0.1% -$3.81K 0.02% 490
2025
Q3 		$4.64M Hold
131,600
– – 0.02% 493
2025
Q2 		$4.74M Buy
131,600
+8,300
+7% +$275K 0.02% 483
2025
Q1 		$3.84M Hold
123,300
– – 0.02% 520
2024
Q4 		$3.15M Buy
+123,300
New +$3.27M 0.01% 560

Other funds holding RPRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

KLP Kapitalforvaltning's RPRX Position: Q3 2026 in Review

KLP Kapitalforvaltning increased its Royalty Pharma (RPRX) stake by 1% in Q3 2026, buying an estimated $94.4K and bringing the position to 159,800 shares worth $9.33M. The position accounts for 0.03% of the portfolio, ranked #406.

KLP Kapitalforvaltning first reported a position in RPRX in Q4 2024 and has held it in 8 quarters since. 393 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • KLP Kapitalforvaltning held 159,800 shares of Royalty Pharma worth $9.33M as of Q3 2026.
  • KLP Kapitalforvaltning bought 1,600 Royalty Pharma shares in Q3 2026, an estimated $94.4K.
  • Royalty Pharma made up 0.03% of KLP Kapitalforvaltning's portfolio in Q3 2026, its #406 holding.
  • KLP Kapitalforvaltning first reported a position in Royalty Pharma in Q4 2024 and has held it in 8 quarters since.
  • 393 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q3 2026, filed 10 Nov 2026.